Following the buzz, shares of Suzlon jumped 7.32 per cent to Rs 27.10 on the BSE.
On the NSE, it climbed 7.32 per cent to Rs 27.10.
Dilip Shanghvi is the founder and managing director of Sun Pharmaceuticals.
As per reports, Dilip Shanghvi will provide as much as Rs 38 billion (USD 610 million) of security for Suzlon Energy Ltd to help the maker of wind turbines fill orders and return to profit.
Meanwhile, earlier this month, Suzlon signed definitive pacts with DSA for equity investment of Rs 1,800 crore in the company, amounting to 23 per cent stake.
DSA also announced an open offer to acquire 26 per cent stake in Suzlon at Rs 18 per share aggregating to Rs 2,837 crore.